Cortek. Inc. – Trademark Portfolio
Entity Type: 03
Cortek. Inc. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 16 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CORTEK. The owner is based in Dedham, MA.
990 Washinaton Street, Suite 210
Dedham, MA 020266790
Showing of trademarks Trademarks
Trademark Classifications
Cortek. Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Cortek. Inc. have?
Cortek. Inc. has 24 U.S. trademarks filed with the USPTO. Of these, 1 registered, 8 abandoned, 15 cancelled.
What trademark classes does Cortek. Inc. file in?
Cortek. Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 37 (Building & Construction). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Cortek. Inc.'s most well-known trademarks?
Cortek. Inc.'s registered trademark portfolio includes well-known marks such as CORTEK. These are among 1 currently registered trademark in the portfolio.
What is Cortek. Inc.'s trademark registration success rate?
Cortek. Inc. has a 4% trademark registration rate, with 1 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.